161 related articles for article (PubMed ID: 36052871)
1. Should adjuvant radiotherapy be used in atypical meningioma (WHO grade 2) following gross total resection? A systematic review and Meta-analysis.
Wujanto C; Chan TY; Soon YY; Vellayappan B
Acta Oncol; 2022 Sep; 61(9):1075-1083. PubMed ID: 36052871
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis.
Chun SW; Kim KM; Kim MS; Kang H; Dho YS; Seo Y; Kim JW; Kim YH; Park CK
Radiat Oncol; 2021 Feb; 16(1):34. PubMed ID: 33596974
[TBL] [Abstract][Full Text] [Related]
3. Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.
Wang C; Kaprealian TB; Suh JH; Kubicky CD; Ciporen JN; Chen Y; Jaboin JJ
Neuro Oncol; 2017 Sep; 19(9):1263-1270. PubMed ID: 28371851
[TBL] [Abstract][Full Text] [Related]
4. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Rogers L; Zhang P; Vogelbaum MA; Perry A; Ashby LS; Modi JM; Alleman AM; Galvin J; Brachman D; Jenrette JM; De Groot J; Bovi JA; Werner-Wasik M; Knisely JPS; Mehta MP
J Neurosurg; 2018 Jul; 129(1):35-47. PubMed ID: 28984517
[TBL] [Abstract][Full Text] [Related]
5. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
6. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
[TBL] [Abstract][Full Text] [Related]
8. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy for atypical meningiomas.
Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
[TBL] [Abstract][Full Text] [Related]
10. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
11. Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control.
Dohm A; McTyre ER; Chan MD; Fan C; Isom S; Bourland JD; Mott RT; Cramer CK; Tatter SB; Laxton AW
J Clin Neurosci; 2017 Dec; 46():90-98. PubMed ID: 28917587
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
Unterberger A; Nguyen T; Duong C; Kondajji A; Kulinich D; Yang I
J Neurooncol; 2021 Apr; 152(2):205-216. PubMed ID: 33635510
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
[TBL] [Abstract][Full Text] [Related]
14. Major complications from radiotherapy following treatment for atypical meningiomas.
Dawley T; Rana Z; Abou-Al-Shaar H; Goenka A; Schulder M
Neurosurg Focus; 2019 Jun; 46(6):E5. PubMed ID: 31153147
[TBL] [Abstract][Full Text] [Related]
15. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy after surgery for benign cerebral meningioma.
Soyuer S; Chang EL; Selek U; Shi W; Maor MH; DeMonte F
Radiother Oncol; 2004 Apr; 71(1):85-90. PubMed ID: 15066300
[TBL] [Abstract][Full Text] [Related]
17. Management trends for anaplastic meningioma with adjuvant radiotherapy and predictors of long-term survival.
Alhourani A; Aljuboori Z; Yusuf M; Woo SY; Hattab EM; Andaluz N; Williams BJ
Neurosurg Focus; 2019 Jun; 46(6):E4. PubMed ID: 31153143
[TBL] [Abstract][Full Text] [Related]
18. The role of adjuvant radiotherapy after gross total resection of atypical meningiomas.
Hasan S; Young M; Albert T; Shah AH; Okoye C; Bregy A; Lo SS; Ishkanian F; Komotar RJ
World Neurosurg; 2015 May; 83(5):808-15. PubMed ID: 25535067
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
